Introduction
Importance of genetic factors in the etiology of schizophrenia and bipolar disorder is well established. However, attempts to identify the susceptibility genes involved have been unsuccessful, and this has led to a search for alternative strategies to overcome the limitations of classical association studies. One such strategy is the use of candidate genes in association studies ( ). Candidate Leboyer et al., 1998 genes are genes that code for proteins involved in the normal functioning of the CNS and whose dysfunctions have been implicated in aetiology of psychiatric disorders. As dopaminergic dysfunction was implicated in the pathophysiology of both psychotic and affective disorders, genes coding for proteins that inactivate dopamine (DA) are good candidate genes for both schizophrenia and bipolar disorders.
At the phenotypical level, the limitations of classical association studies can be overcome by the use of endophenotypes i.e. subclinical traits associated with genetic susceptibility to one or more disorders ( , ) . Endophenotypes are Gottesman and Gould, 2003 Leboyer, 2003 ) and in their relatives ( , ) and therefore constitute and Zakzanis, 1998 Quraishi and Frangou, 2002 Sz ke et al. The fact that DA function influences executive performances suggested the joint use of the two aforementioned strategies. Executive functions depend on the activity of the prefrontal cortex (PFC). DA in the PFC is inactivated primarily by catechol-O-methyl-transferase (COMT). The COMT gene contains a functional polymorphism (Val158Met), resulting in the generation of two forms of COMT, one of which (the Met enzyme) has low activity ( ).
" "
Lotta et al., 1995
Several studies have investigated the association between COMT Val158Met genotypes and EF, as measured by the perseverative errors on the Wisconsin Card Sorting Test (WCST) ( ). Association was observed in relatives of schizophrenic patients (  Table I  Rosa Table   ) . I There are also many studies investigating the influence of this COMT genotype on other executive or non-executive tasks in different normal or pathologic samples (reviewed in and ). As most of these studies did not use the WCST it Bilder et al. 2004 Tunbridge et al. 2006
is difficult to say whether other tasks are better than the WCST for determining the effect of the COMT genotype on cognition. The results from these studies are also difficult to compare because the populations used are often different from those in the studies that used WCST (for example, children with ADHD, patients with Parkinson s disease, subjects with 22q11 deletions, etc.).
'
One exception is the study by Bilder et al. ( ), which used a large range of cognitive tasks in a population of chronic Bilder et al., 2002 schizophrenics. For the EF, this study suggested that other tests, such as the trail making test (TMT), may be more appropriate than the WCST for investigating the effect of COMT.
Other polymorphisms, especially of genes with related functions, may affect EF, thereby masking the effect of the COMT Val158Met polymorphism. In the PFC, the second most important mechanism of DA inactivation is re-uptake by the norepinephrine transporter (NET) (
). The NET contributes to inactivation of both DA and norepinephrine. These neurotransmitters have been implicated in Tzschentke, 2001 the pathophysiology of both schizophrenia and bipolar disorder. Therefore, the NET gene is a functional candidate gene in schizophrenia We therefore investigated the effect of the COMT gene polymorphism not only on the results obtained for the WCST but also on those obtained for the TMT. In addition, we investigated the effect of two NET gene polymorphisms on these two tests of EF.
The first NET gene polymorphism (A1287G) is the only known exonic polymorphism with a high frequency ( ). The Stober et al., 1996 second (T-182C) is located in the promoter region ( ) and may therefore affect the expression of the NET gene.
Zill et al., 2002

Aim of the study
The aim of this study was to replicate previous studies investigating the effect of the COMT gene on EF in schizophrenic subjects, their relatives and controls and to extend their scope by including bipolar patients and their relatives. We also aimed to explore the effect on EF of polymorphisms of a second gene involved in DA inactivation in the PFC (the NET gene).
Methods
Subjects
Probands suffering from schizophrenia, schizoaffective or bipolar disorder were consecutively recruited at two university-affiliated hospitals (the Henri Mondor and Albert Chenevier Hospitals, Cr teil). They were included in the study just before discharge. To be We also asked first-degree relatives of patients to participate in the study. Relatives were interviewed with the DIGS to exclude those presenting a diagnosis of psychotic or bipolar disorder. The information obtained was supplemented, for probands and relatives, if required, with medical case notes.
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COMT and NET genes and executive functions Am J Med Genet B Neuropsychiatr Genet. Author manuscript Page / 3 11 Healthy controls were blood donors at the Piti -Salp tri re Hospital. Controls were included after being interviewed with the DIGS patients also had to be in a stable state, with no change in medication or symptoms for a period of at least two weeks before the cognitive evaluation. Patients and relatives were included only if aged between 18 and 60 years, and if they had no history of neurological disease or current substance abuse. All the subjects included in the study were Caucasian of West European origin.
The research ethics board of Salp tri re Hospital reviewed and approved the study. Written informed consent was obtained from all ê è subjects after the complete description of the study.
Cognitive assessment
We used the classic form of the WCST ( ), with four stimulus cards differing in three characteristics: color (yellow, green, Heaton, 1981 red, blue), shape (triangle, star, cross, circle) and number (one to four) and two identical sets of 64 response cards. The test was discontinued after the completion of six categories or when no more response cards were left. The two measures most often used to assess WCST performance are number of categories completed and number of perseverative errors. However, as the number of categories displays a major ceiling effect, we used only perseverative errors score.
The Trail Making Test (
) is a pencil and paper test assessing psychomotor speed, attention and set Reitan and Wolfson, 1985 alternation. Part A requires the subjects to connect 25 consecutively numbered circles as quickly as possible. In Part B, the subjects have to connect 25 consecutively numbered and lettered circles by alternating between the two sets. The time taken to complete Parts A and B of the TMT is recorded in seconds. As set alternation is required only in Part B, the time taken to complete Part A is subtracted from the time taken to complete Part B to eliminate performance variation due to psychomotor speed ( ), and this value is used as a measure Lezak, 1995 of EF. As some authors report differences between the two parts of the test and others have reported the separate scores for the TMT A and B, we decided to use all three variables in order to facilitate comparison of the data.
The tests were carried out in standardized conditions and scored by three of the authors (two clinical neuropsychologists, A.T. and C.A., and one MD, A.S.) who have extensive practice in these tests.
As schizoaffective subjects show cognitive impairments similar to those of schizophrenic subjects ( , Evans et al., 1999 Gooding and ) those two populations were considered together, as routinely done in other studies ( , Tallent, 2002 Egan et al, 2001 Krabbendam et al.,
). 2001
Genetic analysis
Genomic DNA was extracted from B lymphoblastoid cell lines and the fragments containing the polymorphisms of interest were amplified by polymerase chain reaction (PCR). For COMT, we used the primers COMT F: 5 -CTC ATC ACC ATC GAG ATC AAC and ′ COMT R: 5 -GAT AGT GGG TTT TCA GTG AAC G to generate a 528 bp fragment. 
tatistical methods
Groups of subjects were compared using Chi-square test or Fisher s Exact test for categorical data, and ANOVA for continuous data.
'
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significant variables, by means of stepwise, backward regression. In the regression model, the cognitive measure was the dependent variable. The genotype was the independent variable of interest, and was, as such, forced in the final solution. Demographic variables (sex, age, education level) and group membership were used as covariables and were retained in the final model only if their influence was significant at the 0.1 threshold. We assessed whether the effect of genotype on cognitive measures was affected by group membership by adding a genotype x group interaction factor to the model as a covariable.
As in the groups of patients several factors (such as medication, illness duration etc.) may influence DA metabolism, cognition or both,
we analyzed the whole sample and then separately the schizophrenic, bipolar and healthy (i.e. relatives and controls) subsamples.
Because we had no a priori reasons to consider that the influence of COMT and NET polymorphisms is different in the three groups of healthy individuals we did not analyzed those groups separately unless the genotype x group interaction factor was significant. This strategy avoided unnecessary loss of statistical power (due to smaller samples) and the increase of risk of false positive results (due to multiple statistical tests). Family membership was added as a random effect factor to take into account the lack of independence between family members in analyses including relatives.
Based on previous reports of the influence of the COMT genotype on WCST perseverative errors, we assessed the power of our study to detect similar effects (i.e. 2 5 of shared variance) in our samples. The shared variance (R2) in previous published studies was -% computed based on the reported F value (when not available this value was calculated from the reported data i.e. means and SD), number of subjects, and degrees of freedom see .
- table I All statistical analyses were carried out with SAS V8 software.
Results
We included 318 subjects: 66 schizophrenic or schizoaffective patients (SZ), 57 first-degree relatives of schizophrenic or schizoaffective patients (SZ-Rel), 94 bipolar patients (BP), 51 first-degree relatives of bipolar subjects (BP-Rel) and 50 normal controls (NC). The SZ group included 45 schizophrenic subjects and 21 (30.3 ) schizoaffective subjects.
%
We observed significant differences in demographic variables (age, sex, education level) between the five groups, mainly due to the SZ group, which was younger, and contained a higher proportion of male subjects and individuals with low educational levels (see Table II ). For the two tests of EF used: the worst results were obtained for the SZ group and the best for the NC group ( ). For all cognitive Table II measures (WCST perseverative errors, TMT A, B and B-A), significant differences (at the 0.01 threshold) were observed between schizophrenic patients and their relatives, between the SZ and BP and between SZ and NC groups. BP patients had significantly lower performances than the NC on Trail A and B but not on the WCST or on the TMT B-A. No significant differences were observed between the BP group and their relatives, between the groups of relatives (BP-Rel vs SZ-Rel) or between the groups of relatives and the NC group.
For each group (total sample, healthy subjects i.e. the SZ-Rel, BP-Rel and NC groups combined, SZ patients, BP patients), the genotypes for the three polymorphisms were in Hardy-Weinberg equilibrium. In the total sample and in the subsamples (healthy subjects, schizophrenic patients and bipolar patients), for all three polymorphisms, there were no statistically significant differences in demographic variables when groups defined on the basis of genotype were compared (data not shown).
to summarize the cognitive tests results according to specific genotype, for the four groups analyzed. The results are Tables III V presented as least squares means. These values reflect the effect of genotype after correction for significant demographic variables. As the genotype by group interaction factor was not retained in any of the final models we did not make separate analyses for the two groups of relatives or for controls.
As detailed in to , in all the analyses carried out (for the two EF measures, the three polymorphisms and the four groups) tables III V genotype had no significant effect on cognitive measures (at the 0.05 threshold). No significant differences in the effect of genotype on executive measures were observed when all demographic variables (age, sex, education level and when appropriate group) were retained in the model. Similar results (not shown, to , available on line) were obtained when genotype influence on TMT A and B was tables VI VIII assessed.
We also calculated the power of our study to detect a similar sized association between genotypes and cognitive measures as those In this study, we analyzed the effects of three polymorphisms of two genes involved in DA metabolism in the PFC, on the results obtained in two tests exploring EF (the WCST and the TMT) in schizophrenic, bipolar patients, their relatives and controls. Overall, in our sample we did not found arguments in favor of a significant effect of these polymorphisms on the results obtained on the two cognitive tests. The power calculations suggested that although the combined samples were sufficient to detect a 5 shared variance between the % genotypes and cognitive performances, the individual samples were not. Therefore, we could not rule out a false negative result in the presence of a small effect of genotype on these cognitive measures or whether the effect was limited to one of the sub-samples.
suggested that the effect of the COMT Val/Met polymorphism on performance in the WCST might depend on the Egan et al. (2001) number of alleles present, with Met/Met subjects having the best performances. Our results are not consistent with this hypothesis. The only group in which Met/Met subjects performed best and Val/Val subjects worst was the BP group, but differences were small and, even before correction for multiple testing, far from significant (p 0.33). Thus, although lack of statistical power for analysis of the BP group = may account for the lack of significance observed, this explanation is improbable for the other groups. Three studies on schizophrenic patients showed that Met/Met subjects performed best in the WCST ( , , We also analyzed, for the first time, the effect of two polymorphisms of another gene (the NET gene) involved in DA metabolism in the PFC. The first polymorphism (A1287G) is the only exonic polymorphism of the NET gene occurring at high frequency. This polymorphism had no effect, in any of the groups, on the results obtained in the WCST or the TMT.
The second NET gene polymorphism (C-182T) is located in the promoter region and, as such, may affect NET gene expression. This polymorphism had no significant effect on either task, in any of the groups, but the results obtained were close to the significance threshold (p 0.053) in the SZ group, for the difference score (B-A) of the TMT. The lack of significance of the results may be due to low = statistical power. The absence of such effect in the other groups suggests that, if this polymorphism really does have an effect, it is mediated by characteristics present only in schizophrenic patients (for example, treatment with dopaminergic agents). However, this finding should be interpreted with caution for several reasons. First, multiple statistical tests increase the risk of type 2 error (false positives due to chance finding). Second, this result is mainly the consequence of differences between very low performances in heterozygous subjects and those of the rare C/C subjects. Finally, the lack of or data concerning the influence of this in vitro in vivo polymorphism on NET gene expression limits the possibilities for interpreting this result.
In conclusion, we obtained no evidence that the three polymorphisms studied have an effect on EF in the two tests used here. Despite theoretical considerations, evidence that genes encoding enzymes inactivating DA in the PFC significantly affect EF is weak, and there is even less evidence to suggest that these genes are involved in the etiology of schizophrenia or bipolar disorder by modifying cognition.
Despite these disappointing results, we believe that approaches combining cognitive endophenotypes and candidate genes strategies should be pursued. The choice of other genes and polymorphisms, of other cognitive tests, and the development of more complex interaction models may lead to more consistent positive results. Egan ( 
